Jilin Broadwell Pharmaceutical

Jilin Broadwell Pharmaceutical is a prominent Chinese pharmaceutical company focused on the development and production of treatments for cardiovascular, cerebrovascular, and infectious diseases. Established in 1998 and headquartered in Changchun, the company operates under the well-recognized Boda brand. Its core product portfolio includes high-demand medications such as Alprostadil injections and Ginkgo Biloba extracts, alongside a variety of antibiotic formulations. Broadwell maintains large-scale, GMP-certified manufacturing facilities to support its extensive domestic distribution network. The company is listed on China's National Equities Exchange and Quotations, reflecting its established position in the regional healthcare market.